← Open Payments lookup

KATIE QUICHOCHO: Open Payments

NPI 1245983840 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,906 in 82 payments from 22 companies in 2025. Trend: 2023 $92 · 2024 $1,987 · 2025 $1,906

Food & beverage: $1,857Education: $49
CompanyPaymentsAmount
GENZYME CORPORATION28$807
Lilly USA, LLC6$102
Pharming Healthcare, Inc.5$101
Regeneron Healthcare Solutions, Inc.4$88
Novartis Pharmaceuticals Corporation4$83
Takeda Pharmaceuticals U.S.A., Inc.3$82
BioCryst US Sales Co., LLC4$81
Genentech USA, Inc.3$78
CSL Behring4$68
SANOFI-AVENTIS U.S. LLC1$49

Products named: DUPIXENT, EBGLYSS, RUCONEST, ORLADEYO, Xolair, Rhapsido, OCTAGAM IMMUNE GLOBULIN (HUMAN), Hizentra.

Industry payments across NE — which companies pay providers there.